Literature DB >> 2575717

Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats.

A Pitkänen1, M F Beal, J Sirviö, K J Swartz, P T Männistö, P J Riekkinen.   

Abstract

We studied the effect of pentylenetetrazol (PTZ)-induced kindling (35 mg/kg, i.p., daily) on somatostatin-like immunoreactivity (SOM) with special attention to the duration of changes (rats were sacrificed either 10 days or 4 months after the development of kindling) and to transmitters or modulators related to somatostatin (neuropeptide Y (NPY), GABA, choline acetyltransferase (ChAT), acetylcholinesterase (AchE]. In rats sacrificed 10 days after the last kindled seizure, SOM was elevated in frontal cortex and striatum (p less than 0.01); NPY was elevated in frontal cortex, striatum and hippocampus (p less than 0.05) of kindled or prekindled rats (i.e., rats which were treated daily with PTZ but did not express three consecutive generalized seizures). ChAT activity was slightly decreased (p less than 0.05) in cortex. GABA levels and AchE activity were unchanged in kindled cortex. In rats sacrificed 4 months after the development of kindling none of the parameters analyzed differed from controls. The present study suggests that the cortical and striatal neurons containing SOM/NPY are affected by PTZ-kindling. The cortical cholinergic system is affected to a much smaller extent. The neuropeptide changes are not persistent, as is the lowered seizure threshold, so they are probably not involved in the maintainance of the latter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575717     DOI: 10.1016/0143-4179(89)90045-0

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

Review 1.  Epilepsy as an example of neural plasticity.

Authors:  Helen E Scharfman
Journal:  Neuroscientist       Date:  2002-04       Impact factor: 7.519

2.  Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

Authors:  S C Baraban; G Hollopeter; J C Erickson; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

Review 3.  Gene expression profiling of seizure disorders.

Authors:  Robert C Elliott; Daniel H Lowenstein
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals.

Authors:  J Kragh; N Tønder; B R Finsen; J Zimmer; T G Bolwig
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

5.  Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.

Authors:  Johanna Elms; Kim L Powell; Leena van Raay; Stefanie Dedeurwaerdere; Terence J O'Brien; Margaret J Morris
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

6.  Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus.

Authors:  Marika Nosten-Bertrand; Caroline Kappeler; Céline Dinocourt; Cécile Denis; Johanne Germain; Françoise Phan Dinh Tuy; Soraya Verstraeten; Chantal Alvarez; Christine Métin; Jamel Chelly; Bruno Giros; Richard Miles; Antoine Depaulis; Fiona Francis
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

7.  Antagonism of Histamine H3 receptors Alleviates Pentylenetetrazole-Induced Kindling and Associated Memory Deficits by Mitigating Oxidative Stress, Central Neurotransmitters, and c-Fos Protein Expression in Rats.

Authors:  Alaa Alachkar; Sheikh Azimullah; Mohamed Lotfy; Ernest Adeghate; Shreesh K Ojha; Rami Beiram; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Molecules       Date:  2020-03-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.